Top

Quality of Life Research

Gepubliceerd in:

26-12-2016

Functioning in patients with schizophrenia: a systematic review of the literature using the International Classification of Functioning, Disability and Health (ICF) as a reference

Auteurs: A. Gorostiaga, N. Balluerka, G. Guilera, J. Aliri, M. Barrios

Gepubliceerd in: Quality of Life Research | Uitgave 3/2017

Abstract

Purpose

To identify and quantify the main concepts included in published studies focusing on individuals with schizophrenia using the International Classification of Functioning, Disability and Health (ICF).

Methods

Searches (limited to those published from 2008 to 2012) were performed in MEDLINE, PsycINFO and CINAHL. Included studies described participants with schizophrenia, were original articles and included only subjects who were at least 18 years of age at study entry. All concepts underlying the measures and the text of the articles were extracted, and they were linked to ICF categories using standardized rules.

Results

From the 3584 abstracts retrieved, 348 were randomly selected, and of these, 206 studies met the inclusion criteria. A total of 17,141 concepts were extracted, 84.8% of which could be linked to 491 ICF categories: 222 (45.21%) of the categories referred to Body Functions, 29 (5.91%) to Body Structures, 186 (37.88%) to Activities and Participation and 54 (11%) to Environmental Factors. Seventy second-level categories were reported in at least 5% of all studies: 30 of these categories referred to Body Functions, 2 to Body Structures, 34 to Activities and Participation and 4 to Environmental Factors.

Conclusion

The study has allowed us to identify and quantify the main concepts included in studies focusing on people with schizophrenia using the ICF. The majority of the concepts refer to Body Functions and Activities and Participation, rather than to Body Structures and Environmental Factors.

vorige artikel Effect of exercise on the quality of life in type 2 diabetes mellitus: a systematic review

volgende artikel Appraisal assessment in patient-reported outcome research: methods for uncovering the personal context and meaning of quality of life

Alleen toegankelijk voor geautoriseerde gebruikers

Personal factors refer to the particular background of an individual’s life and circumstances and comprise features of the individual that are not part of a health condition or health states (e.g. gender, race, age, other health conditions, fitness, lifestyle and habits) [9].

Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009). Schizophrenia, “Just the facts” 4. Clinical features and conceptualization. Schizophrenia Research, 110, 1–23. doi:10.1016/j.schres.2009.03.005.CrossRefPubMed

World Health Organization. (2008). The global burden of disease, 2004 update. Geneva: World Health Organization.

Nasrallah, H. A., Duchesne, I., Mehnert, A., Janagap, C., & Eerdekens, M. (2004). Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable Risperidone. Journal of Clinical Psychiatry, 65, 531–536. doi:10.4088/JCP.v65n0412.CrossRefPubMed

Saarni, S. I., Viertiö, S., Perälä, J., Koskinen, S., Lönnqvist, J., & Suvisaari, J. (2010). Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. The British Journal of Psychiatry, 197, 386–394. doi:10.1192/bjp.bp.109.076489.CrossRefPubMed

Green, M. F., Penn, D. L., Bentall, R., Carpenter, W. T., Gaebel, W., Gur, R. C., et al. (2008). Social cognition in schizophrenia: An NIMH workshop on definitions, assessment, and research opportunities. Schizophrenia Bulletin, 34(6), 1211–1220. doi:10.1093/schbul/sbm145.CrossRefPubMedPubMedCentral

Muench, J., & Hamer, A. M. (2010). Adverse effects of antipsychotic medications. American Family Physician, 81, 617–622.PubMed

Cieza, A., & Stucki, G. (2008). The International Classification of Functioning Disability and Health: Its development process and content validity. European Journal of Physical and Rehabilitation Medicine, 44(3), 303–313.PubMed

Bromley, E., & Brekke, J. S. (2010). Assessing function and functional outcome in schizophrenia. In N. R. Swerdlow (Ed.), Behavioral neurobiology of schizophrenia and its treatment (pp. 3–21). Berlin: Springer-Verlag.CrossRef

World Health Organization. (2001). International Classification of Functioning, Disability and Health: ICF. Geneva: World Health Organization.

10.

Cieza, A., Kirchberger, F., Biering-Sorensen, M., Baumberger, S., Charlifue, M. W., Post, R., et al. (2010). ICF Core Sets for individuals with spinal cord injury in the long-term context. Spinal Cord, 48, 305–312. doi:10.1038/sc.2009.183.CrossRefPubMed

11.

Selb, M., Escorpizo, R., Kostanjsek, N., Stucki, G., Ustün, B., & Cieza, A. (2015). A guide on how to develop an international classification of functioning, disability and health core set. European Journal of Physical and Rehabilitation Medicine, 51(1), 105–117.PubMed

12.

Stucki, G., Ewert, T., & Cieza, A. (2003). Value and application of the ICF in rehabilitation medicine. Disability and Rehabilitation, 25, 628–634. doi:10.1080/09638280210148594.CrossRefPubMed

13.

Cieza, A., Ewert, T., Ustün, T. B., Chatterji, S., Kostanjsek, N., & Stucki, G. (2004). Development of ICF Core Sets for patients with chronic conditions. Journal of Rehabilitation Medicine, 44(Suppl), 9–11. doi:10.1080/16501960410015353.

14.

Bickenbach, J. E., Cieza, A., Rauch, A., & Stucki, G. (2012). ICF Core Set: Manual for clinical practice. Göttingen: Hogrefe Publishing.

15.

Brütt, A. L., Schulz, H., & Andreas, S. (2013). Development of an ICF-based core set of activities and participation for patients with mental disorders: An approach based upon data. Clinical Rehabilitation, 27, 758–767. doi:10.1177/0269215513475805.CrossRefPubMed

16.

Pistarini, C., Aiachini, B., Coenen, M., & Pisoni, C. (2011). Functioning and disability in traumatic brain injury: The Italian patient perspective in developing ICF Core Sets. Disability and Rehabilitation, 33, 2333–2345. doi:10.3109/09638288.2011.570414.CrossRefPubMed

17.

Finger, M. E., Glässel, A., Erhart, P., Gradinger, F., Klipstein, A., Rivier, G., et al. (2011). Identification of relevant ICF categories in vocational rehabilitation: A cross sectional study evaluating the clinical perspective. Journal of Occupational Rehabilitation, 21, 156–166. doi:10.1007/s10926-011-9308-2.CrossRefPubMed

18.

Kirchberger, I., Biering-Sorensen, F., Charlifue, S., Baumberger, M., Campbell, R., Kovindha, A., et al. (2010). Identification of the most common problems in functioning of individuals with spinal cord injury using the International Classification of Functioning, Disability and Health. Spinal Cord, 48, 221–229. doi:10.1038/sc.2009.116.CrossRefPubMed

19.

Escorpizo, R., Finger, M. E., Glässel, A., & Cieza, A. (2011). An international expert survey on functioning in vocational rehabilitation using the International Classification of Functioning, Disability and Health. Journal of Occupational Rehabilitation, 21, 147–155. doi:10.1007/s10926-010-9276-y.CrossRefPubMed

20.

Gradinger, F., Boldt, C., Högl, B., & Cieza, A. (2011). Part 2. Identification of problems in functioning of persons with sleep disorders from the health professional perspective using the International Classification of Functioning, Disability and Health (ICF) as a reference: A worldwide expert survey. Sleep Medicine, 12, 97–101. doi:10.1016/j.sleep.2010.08.008.CrossRefPubMed

21.

Post, M. W. M., Kirchberger, I., Scheuringer, M., Wollaars, M. M., & Geyh, S. (2010). Outcome parameters in spinal cord injury research: A systematic review using the International Classification of Functioning, Disability and Health (ICF) as a reference. Spinal Cord, 48, 522–528. doi:10.1038/sc.2009.177.CrossRefPubMed

22.

Ávila, C. C., Cabello, M., Cieza, A., & Vieta, E. (2010). Functioning and disability in bipolar disorders: A systematic review of literature using the ICF as a reference. Bipolar Disorders, 12(5), 473–482. doi:10.1111/j.1399-5618.2010.00833.x.CrossRefPubMed

23.

Zochling, J., Bonjean, M., Grill, E., Scheuringer, M., Stucki, G., & Braun, J. (2006). Systematic review of measures and their concepts used in published studies focusing on the treatment of acute inflammatory arthritis. Clinical Rheumatology, 25, 807–813. doi:10.1007/s10067-005-0156-3.CrossRefPubMed

24.

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PloS Medicine, 6, 1–6.CrossRef

25.

Cieza, A., Geyh, S., Chatterji, S., Kostanjsek, N., Üstün, B., & Stucki, G. (2005). ICF linking rules: An update based on lessons learned. Journal of Rehabilitation Medicine, 37, 212–218. doi:10.1080/16501970510040263.CrossRefPubMed

26.

Cieza, A., & Stucki, G. (2005). Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Quality of Life Research, 14, 1225–1237.CrossRefPubMed

27.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276. doi:10.1093/schbul/13.2.261.CrossRefPubMed

28.

Wechsler, D. (1981). Wechsler adult intelligence scale-revised. San Antonio, TX: Psychological Corporation.

29.

Heaton, R. K., Chelune, G. J., Talley, J. L., Kay, G. G., & Curtiss, G. (1993). Wisconsin card sorting test manual: Revised and expanded. Odessa, FL: Psychological Assessment Resources.

30.

Brockow, T., Cieza, A., Kuhlow, H., Sigl, T., Franke, T., Harder, M., et al. (2004). Identifying the concepts contained in outcome measures of clinical trials on musculoskeletal disorders and chronic wide-spread pain using the International Classification of functioning, Disability and Health as a reference. Journal of Rehabilitation Medicine, 44(Suppl), 30–36. doi:10.1080/16501960410015371.CrossRef

31.

Wolff, B., Cieza, A., Parentin, A., Rauch, A., Sigl, T., Brockow, T., et al. (2004). Identifying the concepts contained in outcome measures of clinical trials on four internal disorders using the International Classification of functioning, Disability and Health as a reference. Journal of Rehabilitation Medicine, 44(Suppl), 37–42. doi:10.1080/16501960410015407.CrossRef

32.

Brockow, T., Wohlfahrt, K., Hillert, A., Gehy, S., Weigl, M., Franke, T., et al. (2004). Identifying the concepts contained in outcome measures of clinical trials on depressive disorders using the International Classification of functioning, Disability and Health as a reference. Journal of Rehabilitation Medicine, 44(Suppl), 49–55. doi:10.1080/16501960410015380.CrossRef

33.

Cabello, M., Mellor-Marsá, B., Sabariego, C., Cieza, A., Bickenbach, J., & Ayuso-Mateos, J. L. (2012). Psychosocial features of depression: A systematic literature review. Journal of Affective Disorders, 141, 22–33. doi:10.1016/j.jad.2011.12.009.CrossRefPubMed

34.

Switaj, P., Anczewska, M., Chrostek, A., Sabariego, C., Cieza, A., & Chatterji, S. (2012). Disability and schizophrenia: A systematic review of experienced psychosocial difficulties. BMC Psychiatry, 12, 193. doi:10.1186/1471-244X-12-193.CrossRefPubMedPubMedCentral

35.

Figueira, M. L., & Brissos, S. (2011). Measuring psychosocial outcomes in schizophrenia patients. Current Opinion in Psychiatry, 24, 91–99. doi:10.1097/YCO.0b013e3283438119.PubMed

36.

Peuskens, J., & Gorwood, P. (2012). How are we assessing functioning in schizophrenia? A need for a consensus approach. European Psychiatry, 27, 391–395. doi:10.1016/j.eurpsy.2011.02.013.CrossRefPubMed

37.

Geyh, S., Cieza, A., Kollerits, B., Grimby, G., & Stucki, G. (2007). Content comparison of health-related quality of life measures used in stroke based on the international classification of functioning, disability and health (ICF): A systematic review. Quality of Life Research, 16, 833–851.CrossRefPubMed

38.

Teixeira-Salmela, L., Neto, M., Magalhaes, L., Lima, R., & Faria, C. (2009). Content comparisons of stroke-specific quality of life based upon the international classification of functioning, disability, and health. Quality of Life Research, 18, 765–773.CrossRefPubMed

39.

Fayed, N., Schiariti, V., Bostan, C., Cieza, A., & Klassen, A. (2011). Health status and QOL instruments used in childhood cancer research: Deciphering conceptual content using World Health Organization definitions. Quality of Life Research, 20, 1247–1258.CrossRefPubMed

40.

Van Roekel, E., Bours, M., Brower, C., Ten Napel, H., Sanduleanu, S., Beets, G., et al. (2014). The applicability of the International Classification of Functioning, Disability, and Health to study lifestyle and quality of life of colorectal cancer survivors. Cancer Epidemiology, Biomarkers and Prevention, 23(7), 1394–1405.CrossRefPubMed

41.

Mueser, K. T., & McGurk, S. R. (2004). Schizophrenia. Lancet, 363(9426), 2063–2072. doi:10.1016/S0140-6736(04)16458-1.CrossRefPubMed

42.

Cieza, A., Chatterji, S., Andersen, C., Cantista, P., Herceg, M., Melvin, J., et al. (2004). ICF Core Sets for depression. Journal of Rehabilitation Medicine, 44(Suppl), 128–134. doi:10.1080/16501960410016055.CrossRef

43.

Bejerholm, U., & Eklund, M. (2004). Time use and occupational performance among persons with schizophrenia. Occupational Therapy in Mental Health, 20(1), 27–47. doi:10.1300/J004v20n01_02.CrossRef

44.

Bellack, A. S. (2006). Scientific and consumer models of recovery in schizophrenia: Concordance, contrasts, and implications. Schizophrenia Bulletin, 32, 432–442. doi:10.1093/schbul/sbj044.CrossRefPubMedPubMedCentral

45.

Karow, A., Moritz, S., Lambert, M., Schöttle, D., Naber, D., & Initiative, E. G. O. F. O. R. S. (2012). Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. European Psychiatry, 27, 401–405. doi:10.1016/j.eurpsy.2011.01.012.CrossRefPubMed

46.

Roick, C., Fritz-Wieacker, A., Matschinger, H., Heider, D., Schindler, J., Riedel-Heller, S., et al. (2007). Health habits of patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 42(4), 268–276. doi:10.1007/s00127-007-0164-5.CrossRefPubMed

47.

Aubin, G., Stip, E., Gélinas, I., Rainville, C., & Chapparo, C. (2009). Daily activities, cognition and community functioning in persons with schizophrenia. Schizophrenia Research, 107(2–3), 313–318. doi:10.1016/j.schres.2008.08.002.CrossRefPubMed

48.

Schretlen, D., Jayaram, G., Maki, P., Park, K., Abebe, S., & DiCarlo, M. (2000). Demographic, clinical, and neurocognitive correlates of everyday functional impairment in severe mental illness. Journal of Abnormal Psychology, 109(1), 134–138. doi:10.1037/0021-843X.109.1.134.CrossRefPubMed

49.

Leifker, F. R., Bowie, C. R., & Harvey, P. D. (2009). Determinants of everyday outcomes in schizophrenia: The influences of cognitive impairment, functional capacity, and symptoms. Schizophrenia Research, 115(1), 82–87. doi:10.1016/j.schres.2009.09.004.CrossRefPubMed

50.

Green, M. F., Kern, R. S., & Heaton, R. K. (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophrenia Research, 72(1), 41–51. doi:10.1016/j.schres.2004.09.009.CrossRefPubMed

51.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Association.CrossRef

52.

Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff”? Schizophrenia Bulletin, 26(1), 119–136. doi:10.1093/oxfordjournals.schbul.a033430.CrossRefPubMed

53.

Barch, D. M. (2005). The cognitive neuroscience of schizophrenia. Annual Review of Clinical Psychology, 1, 321–353. doi:10.1146/annurev.clinpsy.1.102803.143959.CrossRefPubMed

54.

Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., et al. (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry, 56(5), 301–307. doi:10.1016/j.biopsych.2004.06.023.CrossRefPubMed

55.

Heinrichs, R. W. (2005). The primacy of cognition in schizophrenia. The American Psychologist, 60(3), 229–242. doi:10.1037/0003-066X.60.3.229.CrossRefPubMed

56.

Meltzer, H. Y. (2013). Update on typical and atypical antipsychotic drugs. Annual Review of Medicine, 64, 393–406. doi:10.1146/annurev-med-050911-161504.CrossRefPubMed

57.

Rummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Kissling, W., et al. (2012). Second-generation antipsychotic drugs and extrapyramidal side effects: A systematic review and meta-analysis of head-to-head comparisons. Schizophrenia Bulletin, 38(1), 167–177. doi:10.1093/schbul/sbq042.CrossRefPubMed

58.

Ellison-Wright, I., & Bullmore, E. (2010). Anatomy of bipolar disorder and schizophrenia: A meta-analysis. Schizophrenia Research, 117(1), 1–12. doi:10.1016/j.schres.2009.12.022.CrossRefPubMed

59.

Fornito, A., Zalesky, A., Pantelis, C., & Bullmore, E. T. (2012). Schizophrenia, neuroimaging and connectomics. NeuroImage, 62(4), 2296–2314. doi:10.1016/j.neuroimage.2011.12.090.CrossRefPubMed

60.

Minzenberg, M. J., Laird, A. R., Thelen, S., Carter, C. S., & Glahn, D. C. (2009). Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Archives of General Psychiatry, 66(8), 811–822. doi:10.1001/archgenpsychiatry.2009.91.CrossRefPubMedPubMedCentral

61.

Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001). A review of MRI findings in schizophrenia. Schizophrenia Research, 49(1–2), 1–52. doi:10.1016/s0920-9964(01)00163-3.CrossRefPubMedPubMedCentral

62.

Reichenberg, A., & Harvey, P. D. (2007). Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychological Bulletin, 133(5), 833–858. doi:10.1037/0033-2909.133.5.833.CrossRefPubMed

63.

Fujiwara, H., Yassin, W., & Murai, T. (2015). Neuroimaging studies of social cognition in schizophrenia. Psychiatry and Clinical Neurosciences, 69(5), 259–267. doi:10.1111/pcn.12258.CrossRefPubMed

64.

Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., et al. (2012). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. The World Journal of Biological Psychiatry, 13(5), 318–378. doi:10.3109/15622975.2012.696143.CrossRefPubMed

65.

Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., et al. (2013). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. The World Journal of Biological Psychiatry, 14(1), 2–44. doi:10.3109/15622975.2012.739708.CrossRefPubMed

66.

Barnes, T. R. E., & Paton, C. (2011). Antipsychotic polypharmacy in schizophrenia: Benefits and risks. CNS Drugs, 25(5), 383–399. doi:10.2165/11587810-000000000-00000.CrossRefPubMed

67.

Clark, R. E., Bartels, S. J., Mellman, T. A., & Peacock, W. J. (2002). Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: Implications for state mental health policy. Schizophrenia Bulletin, 28(1), 75–84. doi:10.1093/oxfordjournals.schbul.a006928.CrossRefPubMed

68.

Freudenreich, O., & Goff, D. C. (2002). Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatrica Scandinavica, 106(5), 323–330. doi:10.1034/j.1600-0447.2002.01331.x.CrossRefPubMed

69.

Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009). Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin, 35, 383–402. doi:10.1093/schbul/sbn135.CrossRefPubMed

Titel: Functioning in patients with schizophrenia: a systematic review of the literature using the International Classification of Functioning, Disability and Health (ICF) as a reference
Auteurs: A. Gorostiaga
N. Balluerka
G. Guilera
J. Aliri
M. Barrios
Publicatiedatum: 26-12-2016
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 3/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-016-1488-y

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 3/2017

Responsiveness of SF-36 Health Survey and Patient Generated Index in people with chronic knee pain commenced on oral analgesia: analysis of data from a randomised controlled clinical trial

Appraisal assessment in patient-reported outcome research: methods for uncovering the personal context and meaning of quality of life

Improving measures of work-related physical functioning

Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilience

Impact of IRT item misfit on score estimates and severity classifications: an examination of PROMIS depression and pain interference item banks

Art therapy based on appreciation of famous paintings and its effect on distress among cancer patients